The Case Manager: Driving Medical Reasoning in a Distributed Environment for Home Patient Monitoring.

The CAPABLE project has been funded by the EU Horizon 2020 Programme over the years 2020-24 to support home care. A system is being designed and implemented supporting remote monitoring and virtual coaching for cancer patients. The system is based on a distributed modular architecture involving many components encapsulating various knowledge. The Case Manager has been designed as a separate component with the aim of coordinating the problem solving strategies. A first version of the Case Manager has been released and used by the components in a prototypical scenario shown at the first project review

CAncer PAtients Better Life Experience (CAPABLE) First Proof-of-Concept Demonstration

The CAncer PAtient Better Life Experience (CAPABLE) project combines the most advanced technologies for data and knowledge management with a socio-psychological approach, to develop a coaching system for improving the quality of life of cancer patients managed at home. The team includes complementary expertise in data- and knowledge-driven AI, data integration, telemedicine and decision support. The time is right to fully exploit Artificial Intelligence for cancer care and bring the benefits right to patients’ homes. CAPABLE relies on predictive models based on both retrospective and prospective data, integrated with computer interpretable guidelines and made available to oncologists. CAPABLE’s Virtual Coach component identifies unexpected needs and provides patient-specific decision support and lifestyle guidance to improve mental and physical wellbeing of patients. The demo, designed around a use-case scenario developed with clinicians involved in the project, addresses the ESMO Diarrhea guideline. It revolves around a prototypical fictional patient named Maria. Maria, 66, is affected by renal cell carcinoma and moderate insomnia. The demo follows Maria during the first three days of using the CAPABLE system. This allows the audience to understand the scope and innovation behind this AI-based decision-support and coaching system that personalizes lifestyle and medication interventions to patients, their carer and clinicians

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

BackgroundSince treatment with immune checkpoint inhibitors (ICIs) is becoming standard therapy for patients with high-risk and advanced melanoma, an increasing number of patients experience treatment-related adverse events such as fatigue. Until now, studies have demonstrated the benefits of using eHealth tools to provide either symptom monitoring or interventions to reduce treatment-related symptoms such as fatigue. However, an eHealth tool that facilitates the combination of both symptom monitoring and symptom management in patients with melanoma treated with ICIs is still needed. ObjectiveIn this pilot study, we will explore the use of the CAPABLE (Cancer Patients Better Life Experience) app in providing symptom monitoring, education, and well-being interventions on health-related quality of life (HRQoL) outcomes such as fatigue and physical functioning, as well as patients’ acceptance and usability of using CAPABLE. MethodsThis prospective, exploratory pilot study will examine changes in fatigue over time in 36 patients with stage III or IV melanoma during treatment with ICI using CAPABLE (a smartphone app and multisensory smartwatch). This cohort will be compared to a prospectively collected cohort of patients with melanoma treated with standard ICI therapy. CAPABLE will be used for a minimum of 3 and a maximum of 6 months. The primary endpoint in this study is the change in fatigue between baseline and 3 and 6 months after the start of treatment. Secondary end points include HRQoL outcomes, usability, and feasibility parameters. ResultsStudy inclusion started in April 2023 and is currently ongoing. ConclusionsThis pilot study will explore the effect, usability, and feasibility of CAPABLE in patients with melanoma during treatment with ICI. Adding the CAPABLE system to active treatment is hypothesized to decrease fatigue in patients with high-risk and advanced melanoma during treatment with ICIs compared to a control group receiving standard care. The Medical Ethics Committee NedMec (Amsterdam, The Netherlands) granted ethical approval for this study (reference number 22-981/NL81970.000.22). Trial RegistrationClinicalTrials.gov NCT05827289; https://clinicaltrials.gov/study/NCT05827289 International Registered Report Identifier (IRRID)DERR1-10.2196/4925